🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 23 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/06/2022 33,85 34,34 31,85 33,05 -0,93% 7,36% 791.000
31/05/2022 34,14 34,51 32,69 33,36 -2,46% 5,33% 761.200
27/05/2022 33,57 34,25 32,50 34,20 +2,61% 5,21% 753.700
26/05/2022 33,38 34,84 33,32 33,33 -1,88% 4,55% 768.000
25/05/2022 33,52 34,27 32,78 33,97 +0,50% 4,45% 529.500
24/05/2022 35,29 35,51 33,48 33,80 -6,24% 5,75% 782.900
23/05/2022 36,45 36,88 35,49 36,05 -0,44% 3,81% 577.700
20/05/2022 36,01 36,64 33,90 36,21 +3,02% 7,61% 735.600
19/05/2022 34,07 35,80 33,80 35,15 +2,78% 5,87% 881.100
18/05/2022 35,08 36,14 34,08 34,20 -4,39% 5,87% 1.328.100
17/05/2022 33,97 35,77 33,58 35,77 +8,79% 6,44% 1.236.200
16/05/2022 31,52 34,19 31,00 32,88 +3,92% 10,12% 1.136.900
13/05/2022 31,03 33,21 30,74 31,64 +4,39% 7,96% 1.288.100
12/05/2022 28,45 31,28 27,87 30,31 +4,70% 11,99% 1.480.000
11/05/2022 35,30 35,50 28,53 28,95 -15,57% 19,75% 1.956.600
10/05/2022 34,72 35,47 33,36 34,29 +4,80% 6,08% 1.418.900
09/05/2022 35,82 36,52 32,24 32,72 -11,38% 11,95% 1.599.700
06/05/2022 39,39 39,49 36,48 36,92 -8,25% 7,64% 1.088.300
05/05/2022 42,59 42,69 39,14 40,24 -6,44% 8,34% 696.500
04/05/2022 42,99 43,23 40,11 43,01 +0,84% 7,26% 808.500
03/05/2022 42,91 44,60 41,99 42,65 -0,93% 6,08% 578.200
02/05/2022 41,09 43,13 40,76 43,05 +4,72% 5,76% 706.700
29/04/2022 42,07 43,43 40,83 41,11 -2,84% 6,18% 548.700
28/04/2022 42,23 42,59 39,66 42,31 +1,68% 6,94% 546.400
27/04/2022 40,98 42,47 40,40 41,61 +1,71% 5,05% 839.900
26/04/2022 43,18 43,89 40,88 40,91 -6,83% 6,98% 838.100
25/04/2022 42,31 44,04 42,08 43,91 +2,93% 4,63% 448.100
22/04/2022 42,74 43,43 42,01 42,66 -0,19% 3,32% 578.900
21/04/2022 46,49 47,20 42,50 42,74 -6,60% 10,11% 609.500
20/04/2022 46,00 46,20 44,37 45,76 +0,59% 3,98% 531.300